Stock Track | Clover Health Soars After-Hours on New CMO Hire at Healthcare Tech Subsidiary

Stock Track

2024-10-09

Shares of Clover Health Corp (CLOV) surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.

Counterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companies like Cue Health, Apple, and New York-Presbyterian hospital.

The addition of Dr. Tsay to Counterpart Health's leadership team is seen as a positive development for Clover Health, which is focused on expanding its healthcare technology offerings and capabilities in value-based care models. Investors appear to be reacting favorably to the news, betting that Tsay's expertise can help drive further innovation and growth at Counterpart Health's AI physician enablement platform.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1152133462"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1152133462\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1152133462?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-09 05:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152133462","market":"us","top_or_hot":-1,"title":"Stock Track | Clover Health Soars After-Hours on New CMO Hire at Healthcare Tech Subsidiary","media":"Stock Track","content":"<html><body><p>Shares of Clover Health Corp (CLOV) surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.</p>\n<p>Counterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companies like Cue Health, Apple, and New York-Presbyterian hospital.</p>\n<p>The addition of Dr. Tsay to Counterpart Health's leadership team is seen as a positive development for Clover Health, which is focused on expanding its healthcare technology offerings and capabilities in value-based care models. Investors appear to be reacting favorably to the news, betting that Tsay's expertise can help drive further innovation and growth at Counterpart Health's AI physician enablement platform.</p></body></html>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Stock Track | Clover Health Soars After-Hours on New CMO Hire at Healthcare Tech Subsidiary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Clover Health Soars After-Hours on New CMO Hire at Healthcare Tech Subsidiary\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-10-09 05:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Clover Health Corp (CLOV) surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.</p>\n<p>Counterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companies like Cue Health, Apple, and New York-Presbyterian hospital.</p>\n<p>The addition of Dr. Tsay to Counterpart Health's leadership team is seen as a positive development for Clover Health, which is focused on expanding its healthcare technology offerings and capabilities in value-based care models. Investors appear to be reacting favorably to the news, betting that Tsay's expertise can help drive further innovation and growth at Counterpart Health's AI physician enablement platform.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLOV","symbol_name":"Clover Health Corp","start_time":0,"source_url":"","article_id":"1152133462","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152133462","pubTimestamp":1728421253,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Clover Health Corp  surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.Counterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companie","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLOV":"Clover Health Corp"},"translate_title":"医疗保健科技子公司聘请新首席营销官后，Clover Health盘后股价飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLOV":1},"content_text":"Shares of Clover Health Corp (CLOV) surged over 5% in after-hours trading on Monday, following the announcement that its subsidiary Counterpart Health has appointed Dr. David Tsay as its new Chief Medical Officer.\nCounterpart Health, Clover's AI-powered physician enablement platform, revealed on Monday that it has named David Tsay M.D., Ph.D as its new CMO. Dr. Tsay brings over two decades of experience in health technology, product development, and clinical innovation from leadership roles at companies like Cue Health, Apple, and New York-Presbyterian hospital.\nThe addition of Dr. Tsay to Counterpart Health's leadership team is seen as a positive development for Clover Health, which is focused on expanding its healthcare technology offerings and capabilities in value-based care models. Investors appear to be reacting favorably to the news, betting that Tsay's expertise can help drive further innovation and growth at Counterpart Health's AI physician enablement platform.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}